https://www.jns.org/david-adler Professor David Adler is a senior pharmaceutical leader in oncology clinical drug development and translational medicine. He spent a decade in senior leadership within Bayer AG’s Global Oncology Clinical Development organization and currently serves as chief scientific and medical officer of the PATHORA Institute of Pathology & Tissue Medicine, alongside academic appointments at the Hebrew University of Jerusalem, Ben-Gurion University of the Negev and the University of Bonn. en-US Sun, 23 Aug 2026 03:00:00 GMT https://www.jns.org/opinion/david-adler/an-overlooked-opportunity-for-israel-and-saudi-arabia 000001a0-2043-dfc0-a9bc-ed6f3c710002 Sun, 23 Aug 2026 03:00:00 GMT https://www.jns.org/opinion/david-adler/an-overlooked-opportunity-for-israel-and-saudi-arabia